Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A.

Pozzi O, Misiano P, Clark GD, Visentin L.

Pharmacology. 2003 Nov;69(3):158-63.

PMID:
14512703
2.
3.
4.
5.

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.

Cui YY, D'Agostino B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmona M, Rossi F, Advenier C.

Eur J Pharmacol. 2007 Nov 14;573(1-3):206-13. Epub 2007 Jul 3.

PMID:
17643417
8.

Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.

Ding Z, Cowan A, Rawls SM.

Brain Res. 2005 Dec 14;1065(1-2):147-51. Epub 2005 Nov 23.

PMID:
16309633
9.

Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat.

Yüce B, Kemmer M, Qian G, Müller M, Sibaev A, Li Y, Kreis ME, Storr M.

Neurogastroenterol Motil. 2010 Jun;22(6):672-e205. doi: 10.1111/j.1365-2982.2010.01473.x. Epub 2010 Feb 18.

PMID:
20158615
11.

Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

Castañé A, Maldonado R, Valverde O.

Br J Pharmacol. 2004 Aug;142(8):1309-17. Epub 2004 Jul 20.

12.

The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.

Fukuda H, Abe T, Yoshihara S.

Int Arch Allergy Immunol. 2010;152(3):295-300. doi: 10.1159/000283042. Epub 2010 Feb 12.

PMID:
20150748
13.

WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.

Rodvelt KR, Bumgarner DM, Putnam WC, Miller DK.

Life Sci. 2007 Jan 2;80(4):337-44. Epub 2006 Sep 30.

PMID:
17067637
14.

Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.

Izzo AA, Mascolo N, Capasso R, Germanò MP, De Pasquale R, Capasso F.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):221-3.

PMID:
10494894
15.

Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.

Accorsi-Mendonça D, Almado CE, Dagostin AL, Machado BH, Leão RM.

Brain Res. 2008 Mar 20;1200:1-9. doi: 10.1016/j.brainres.2008.01.011. Epub 2008 Jan 16.

PMID:
18308297
16.

Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.

Mendiguren A, Pineda J.

Eur J Pharmacol. 2006 Mar 18;534(1-3):83-8. Epub 2006 Feb 14.

PMID:
16483566
17.

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.

Fattore L, Cossu G, Martellotta CM, Fratta W.

Psychopharmacology (Berl). 2001 Aug;156(4):410-6.

PMID:
11498718
18.
19.

Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.

Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH.

J Pharmacol Exp Ther. 1998 Aug;286(2):697-703.

PMID:
9694923
20.

Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.

Liu Q, Bhat M, Bowen WD, Cheng J.

J Pharmacol Exp Ther. 2009 Dec;331(3):1062-70. doi: 10.1124/jpet.109.156216. Epub 2009 Sep 14.

Supplemental Content

Support Center